Loading...
K Pharma,Inc.
4896.T•JPX
Healthcare
Biotechnology
¥726.00
¥-9.00(-1.22%)
K Pharma,Inc. (4896.T) Financial Performance & Income Statement Overview
Review K Pharma,Inc. (4896.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-328.47%
↓ 328.47%
Net Income Growth
-425.15%
↓ 425.15%
Operating Cash Flow Growth
-316.48%
↓ 316.48%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-34.28%
↓ 34.28%
ROIC
-38.47%
↓ 38.47%
K Pharma,Inc. (4896.T) Income Statement & Financial Overview
View the income breakdown for K Pharma,Inc. 4896.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $121.18M | $93.67M | $0.00 | $148.60M |
| SG&A Expenses | $94.18M | $103.83M | $192.70M | $82.18M |
| Operating Expenses | $215.36M | $197.50M | $192.70M | $230.78M |
| Total Costs & Expenses | -$215.36M | -$197.50M | $192.70M | $230.78M |
| Interest Income | $0.00 | $251000.00 | $0.00 | $14000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $2.10M |
| EBITDA | -$221.56M | -$197.20M | -$192.70M | -$228.69M |
| EBITDA Ratio | ||||
| Operating Income | -$215.36M | -$197.50M | -$192.70M | -$230.78M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$6.20M | $295000.00 | $225000.00 | -$2.08M |
| Income Before Tax | -$221.56M | -$197.20M | -$192.48M | -$232.87M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $577000.00 | $616000.00 | $578000.00 | $579000.00 |
| Net Income | -$222.13M | -$197.82M | -$193.06M | -$233.45M |
| Net Income Ratio | ||||
| EPS | -$19.14 | -$17.05 | -$16.64 | -$20.12 |
| Diluted EPS | -$19.14 | -$17.05 | -$16.64 | -$20.12 |
| Weighted Avg Shares Outstanding | $11.60M | $11.60M | $11.60M | $11.60M |
| Weighted Avg Shares Outstanding (Diluted) | $11.60M | $11.60M | $11.60M | $11.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan